Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals is a biotechnology company utilizing deuterium todevelop novel medical candidates.
Type
B2b
Founded
2006
Raised
$125.5M
Follow us
Alexa global traffic share
Latest funding Show all
$30,000,000
Post-IPO debt - 2017
Hercules Capital, Inc.
Team Size
50+
Employees
$30,000,000 Post-IPO debt
businesswire , PE HUB

Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital

$48,500,000 Venture capital (Series B)
Added by
via PE Hub

Concert Pharma Raises $48.5 Million